Resistance training key to maintaining muscle function during GLP-1 weight loss, study shows

A study published in Nature Medicine suggests that resistance training is essential for patients using GLP-1 weight-loss medications. The research indicates that combining exercise with drugs like tirzepatide helps preserve muscle mass and strength while reducing body fat.
Why it matters
As GLP-1 drugs become widely used, understanding how to mitigate the loss of lean muscle mass is critical for long-term metabolic health and physical function.
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: MART PRODUCTION from Pexels A study has revealed that resistance (weight) training not only preserves lean and muscle mass but also increases strength in people taking weight-loss medication. Published in Nature Medicine , the Tirzepatide and Resistance Exercise (T-REx) study is the first to show the effects of combining a GLP-1 medicine and resistance training on body composition, muscle mass, strength and a range of cardiovascular health measures.
Drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro) are commonly used for weight loss and have been found to improve chronic health conditions, reduce risk of obesity-related cardiovascular diseases , and enhance quality of life.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in